These findings suggest the pathobiological importance of SPOP, RPL3 and other translational elongation and ribosome biogenesis CPGs in AT as a novel class of potential non‐malignant tissue clinical biomarkers for malignancy diagnostics, the prognosis of tumor aggressiveness and ‘anti‐cancerization’ tissue therapeutic targeting. The gene discussed is RPL3; the disease is neoplasm.